title: Thrombomodulin expression on Langerhans' islet: can endogenous 'anticoagulant on demand' overcome detrimental thrombotic complications in clinical islet transplantation?
authors.forename: S
authors.initials: S
authors.lastname: Iino
authors.forename: K
authors.initials: K
authors.lastname: Abeyama
authors.forename: K-I
authors.initials: KI
authors.lastname: Kawahara
authors.forename: T
authors.initials: T
authors.lastname: Aikou
authors.forename: I
authors.initials: I
authors.lastname: Maruyama
mesh_terms: D000818:Animals; D006801:Humans; D007515:Islets of Langerhans / Q000737:chemistry*; D016381:Islets of Langerhans Transplantation / Q000009:adverse effects; D051379:Mice; D018180:Thrombomodulin / Q000032:analysis* / Q000502:physiology; D013925:Thromboplastin / Q000032:analysis / Q000502:physiology; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control
chemical_list: D018180:Thrombomodulin; D013925:Thromboplastin